FilingReader Intelligence

Zydus Lifesciences reports 6% revenue growth to ₹65.7bn

August 20, 2025 at 07:08 PM UTCBy FilingReader AI

Zydus Lifesciences reported consolidated revenues of ₹65.7 billion for Q1 FY26, up 6% year-on-year, with net profit of ₹14.7 billion, up 3%.

The company's international markets formulations business recorded strong 37% growth to ₹7.3 billion, while India branded formulations grew 9%. US formulations business grew 3% with 3 new product launches.

Zydus achieved a net cash position of ₹56.3 billion, up from ₹48.8 billion previously.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

BSE:ZYDUSLIFEBombay Stock Exchange

News Alerts

Get instant email alerts when Zydus Lifesciences publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →